APA

Wang Z., Huang C., Yang J., Song Y., Cheng Y., Chen G., Yan H., Ben X., Wang B., Xu C., Jiang B., Zhou Q., Chen H. & Wu Y. (20200521). A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). : European journal of cancer (Oxford, England : 1990).

Chicago

Wang Zhen, Huang Cheng, Yang Jin-Ji, Song Yong, Cheng Ying, Chen Gong-Yan, Yan Hong-Hong, Ben Xiao-Song, Wang Bin-Chao, Xu Chong-Rui, Jiang Ben-Yuan, Zhou Qing, Chen Hua-Jun and Wu Yi-Long. 20200521. A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). : European journal of cancer (Oxford, England : 1990).

Harvard

Wang Z., Huang C., Yang J., Song Y., Cheng Y., Chen G., Yan H., Ben X., Wang B., Xu C., Jiang B., Zhou Q., Chen H. and Wu Y. (20200521). A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). : European journal of cancer (Oxford, England : 1990).

MLA

Wang Zhen, Huang Cheng, Yang Jin-Ji, Song Yong, Cheng Ying, Chen Gong-Yan, Yan Hong-Hong, Ben Xiao-Song, Wang Bin-Chao, Xu Chong-Rui, Jiang Ben-Yuan, Zhou Qing, Chen Hua-Jun and Wu Yi-Long. A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002). : European journal of cancer (Oxford, England : 1990). 20200521.